{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:10:34Z","timestamp":1769184634311,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.semarthrit.2022.152071","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:42:49Z","timestamp":1657946569000},"page":"152071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-5769","authenticated-orcid":false,"given":"Philip","family":"Therkildsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"de Thurah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel","family":"Faurschou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Baslund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ib T\u00f8nder","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit Dalsgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen-Margrethe","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2022.152071_bib0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.280.4.385","article-title":"Visual Loss in Giant Cell Arteritis","volume":"280","author":"Gordon","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0003","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual Manifestations of Giant Cell Arteritis: trends and Clinical Spectrum in 161 Patients","volume":"79","author":"Gonz\u00e1lez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0004","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0005","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3899\/jrheum.151033","article-title":"Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: a Population-based Study","volume":"43","author":"Saleh","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0008","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0009","first-page":"103-6","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"33","author":"Patil","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0011","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0012","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2007.10.014","article-title":"The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis","volume":"38","author":"Lopez-Diaz","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0013","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0014","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0016","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0017","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/CLEP.S258219","article-title":"Positive Predictive Value of the Giant Cell Arteritis Diagnosis in the Danish National Patient Registry: a Validation Study","volume":"12","author":"Hjort","year":"2020","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0018","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/CLEP.S9908","article-title":"Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank","year":"2010","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0019","first-page":"155","article-title":"Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012","volume":"6","author":"M","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CLEP.S17901","article-title":"Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark","volume":"3","author":"Grann","year":"2011","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0962280209105020","article-title":"Pseudo-observations in survival analysis","volume":"19","author":"Andersen","year":"2010","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.01.007","article-title":"Giant cell arteritis: a nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment","author":"Therkildsen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0024","article-title":"All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study","author":"Therkildsen","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0025","article-title":"Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study","author":"Therkildsen","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0026","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0027","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03009742.2016.1266030","article-title":"Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden","volume":"46","author":"Ji","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"AP","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.152071_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-eular.3213","article-title":"SAT0256\u2005The role of fast-track ultrasound in preventing early complications and relapses in giant cell arteritis","volume":"79","author":"Delvino","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:11:17Z","timestamp":1758733877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"alternative-id":["S0049017222001226"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152071","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152071"}}